| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 419 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 416 |
| 2 | TACROLIMUS OINTMENT 0.1% | 416 |
| 3 | PREDNISOLONE | 389 |
| 4 | PREDNISOLONE ORAL | 389 |
| 5 | PREDNISOLONE ORAL SOLUTION | 389 |
| 6 | MYCOPHENOLATE MOFETIL | 310 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 310 |
| 8 | PREDNISONE | 215 |
| 9 | RITUXIMAB | 204 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRANACOGENE DEZAPARVOVEC | 5 | 0.0769 |
| 1 | SODIUM CARBONATE | 2 | 0.0085 |
| 2 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 3 | DICLOFENAC SODIUM/MISOPROSTOL | 2 | 0.0045 |
| 4 | CARMUSTINE | 21 | 0.0045 |
| 5 | PREDNISOLONE SODIUM PHOSPHATE | 11 | 0.0044 |
| 6 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 7 | EVEROLIMUS TABLETS | 73 | 0.0043 |
| 8 | MYCOPHENILIC ACID | 88 | 0.0041 |
| 9 | PURIXAN | 3 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 721 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 215 |
| 2 | Nucleoside Analog Antiviral [EPC] | 193 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 185 |
| 4 | Alkylating Drug [EPC] | 178 |
| 5 | Kinase Inhibitor [EPC] | 151 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 100 |
| 7 | Proton Pump Inhibitor [EPC] | 89 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 88 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 75 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 88 | 0.0041 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 2 | Nucleoside Analog Antiviral [EPC] | 193 | 0.0023 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 10 | 0.0013 |
| 5 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 6 | 0.0012 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 14 | 0.0010 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 8 | Alkylating Drug [EPC] | 178 | 0.0007 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 215 | 0.0007 |